FSL0482
- Structure
- InChI=1S/C53H100N16O13/c1-9-30(6)12-10-11-13-41(72)60-33(14-20-54)48(77)69-43(32(8)71)53(82)65-36(17-23-57)45(74)64-38-19-25-59-52(81)42(31(7)70)68-49(78)37(18-24-58)62-44(73)34(15-21-55)63-50(79)39(26-28(2)3)67-51(80)40(27-29(4)5)66-46(75)35(16-22-56)61-47(38)76/h28-40,42-43,70-71H,9-27,54-58H2,1-8H3,(H,59,81)(H,60,72)(H,61,76)(H,62,73)(H,63,79)(H,64,74)(H,65,82)(H,66,75)(H,67,80)(H,68,78)(H,69,77)
- InChIKey=XDJYMJULXQKGMM-UHFFFAOYSA-N
- Synonyms
-
- 1264-72-8
- 7722-44-3
- Belcomycin
- Colimycin
- Colistin
- Colistin A
- Colymycin
- Polymixin E1
- Polymyxin E1
- Polymyxin-E
- Torazin
- Origin
- Paenibacillus polymyxa var. colistinus
- Biological activities
- Disruption of the outer cell membrane of Gram-negative bacilli
- Therapeutic
-
Antibacterial
- Target
-
Bacterial outer cell membrane
- Assay information
-
Binding and neutralizing lipopolysaccharide (LPS) and preventing the pathophysiologic effects of endotoxin in the circulation
Binding to phospholipids in the outer cell membrane of Gram-negative bacteria. Competitively displaces divalent cations from the phosphate groups of membrane lipids, which leads to disruption of the outer cell membrane, leakage of intracell
MICs for susceptible strains, 1 to 4 μg/ml MICs for resisrant strains were >gt;128 μg/ml
Effective antimicrobial effect in vivo using E. coli infected mice at 1 mg/Kg